Syndax Pharmaceuticals Inc — Form 10-Q
Filed August 4, 2026 · analyzed by the Periodic Agent
10-Q
— Neutral
significance 12/100
What the filing says
Syndax filed template forms for equity grants under its 2026 Equity Incentive Plan: Stock Option Grant Notices (Exhibits 10.2), RSU Award Grant Notices with standard vesting (Exhibit 10.3), and RSU Award Grant Notices with restricted settlement tied to separation/change of control (Exhibit 10.4). No specific grants, counterparties, dollar amounts, share counts, or grant dates are disclosed—these are blank boilerplate templates establishing the framework for future equity awards to employees.
Why this rating
Boilerplate equity plan templates with no actual grants disclosed. Administrative filing establishing future grant mechanics, not a material business event or transaction.
See more from August 4, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.